Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for BEHANDLUNG VON PEDIATRISCHEN TYP-2-DIABETES MELLITUS PATIENTEN MIT LIXISENATIDE
Details for 2016700758
Up to date per 13.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2016700758
Title / Product Name
BEHANDLUNG VON PEDIATRISCHEN TYP-2-DIABETES MELLITUS PATIENTEN MIT LIXISENATIDE
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2016700758
EP Publication Number
3244912
E-Number
1421014
Language
EN
PCT Number
EP16050804
Publication Date
22.11.2017 A
18.08.2021 B1
Registration Date
18.08.2021
AT Publication Date
15.09.2021
Application Date
15.01.2016
Registration Number
-
Priorities
16.01.2015
EP
15151488
IPC
A61K 38/26 20060101AFI20160729BHEP
Maximum Duration of Protection
15.01.2036
Owner
Sanofi-Aventis Deutschland GmbH
Brüningstraße 50
65929 Frankfurt
DE
Representative
Representative
Häupl & Ellmeyer KG, Patentanwaltskanzlei
Mariahilfer Straße 50 (Eingang Kirchengasse 1)
1070 Wien
AT
Inventor
BERGMANN, Karin
Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main
DE
HINCELIN-MÉRY, Agnès
Sanofi Département Brevets 54 Rue La Boétie
75008 Paris
FR
JAN, Christelle
Sanofi Département Brevets 54 Rue La Boétie
75008 Paris
FR
Information about Fees
Click here to load the fees